I agree that this site is using cookies. You can find further informations here.
X
Weckstein, Douglas J
20  results:
Search for persons X
?
1

Cetuximab and Irinotecan With or Without Bevacizumab in Ref..:

Lipsyc-Sharf, Marla ; Ou, Fang-Shu ; Yurgelun, Matthew B...
The Oncologist.  27 (2022)  4 - p. 292-298 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Cardiac outcomes of subjects on adjuvant trastuzumab emtans..:

Barroso-Sousa, Romualdo ; Tarantino, Paolo ; Tayob, Nabihah...
npj Breast Cancer.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
3

Chemotherapy-related amenorrhea (CRA) after adjuvant ado-tr..:

Ruddy, Kathryn J. ; Zheng, Yue ; Tayob, Nabihah...
Breast Cancer Research and Treatment.  189 (2021)  1 - p. 103-110 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementa..:

Brown, Justin C. ; Rosenthal, Michael H. ; Ma, Chao...
Cancers.  12 (2020)  11 - p. 3451 , 2020
Link: https://doi.org/10.3390/..
 
?
5

Phase II trial of RAD001 and bicalutamide for castration‐re..:

Nakabayashi, Mari ; Werner, Lilian ; Courtney, Kevin D....
BJU International.  110 (2012)  11 - p. 1729-1735 , 2012
Link: https://doi.org/10.1111/..
 
?
6

Differences in affinities of muscarinic acetylcholine recep..:

Gibson, Raymond E. ; Rzeszotarski, Waclaw J. ; Eckelman, William C....
Biochemical Pharmacology.  32 (1983)  12 - p. 1851-1856 , 1983
Link: https://doi.org/10.1016/..
 
?
7

Cetuximab and Irinotecan With or Without Bevacizumab in Ref..:

Lipsyc-Sharf, Marla ; Ou, Fang-Shu ; Yurgelun, Matthew B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982431/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Effect of High-Dose vs Standard-Dose Vitamin D(3) Supplemen..:

Brown, Justin C ; Rosenthal, Michael H ; Ma, Chao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699725/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Effect of High-Dose vs Standard-Dose Vitamin D(3) Supplemen..:

Ng, Kimmie ; Nimeiri, Halla S ; McCleary, Nadine J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459117/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
10

Feasibility Assessment of Patient Reporting of Symptomatic ..:

Basch, Ethan ; Dueck, Amylou C ; Rogak, Lauren J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553624/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
11

Feasibility Assessment of Patient Reporting of Symptomatic ..:

Basch, Ethan ; Dueck, Amylou C ; Rogak, Lauren J...
qt0f02s9jq.  , 2017
Link: https://escholarship.org..
 
?
12

Effect of Longer-Interval vs Standard Dosing of Zoledronic ..:

Himelstein, Andrew L ; Foster, Jared C ; Khatcheressian, James L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321662/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Molecular Heterogeneity and Response to Neoadjuvant Human E..:

Carey, Lisa A ; Berry, Donald A ; Cirrincione, Constance T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980567/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
14

Assessment of Perceived Cost to the Patient and Other Barri..:

Weckstein, Douglas J ; Thomas, Christian A ; Emery, Ivette F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170068.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
15

Implementing a Geriatric Assessment in Cooperative Group Cl..:

Hurria, Arti ; Cirrincione, Constance T ; Muss, Hyman B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083997.  , 2011
Link: http://www.ncbi.nlm.nih...
 
1-15